C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/30 (2006.01) A61K 31/4468 (2006.01) A61K 31/4523 (2006.01) A61K 31/46 (2006.01) A61P 1/00 (2006.01) A61P 17/00 (2006.01) A61P 19/00 (2006.01) C07D 211/58 (2006.01) C07D 405/06 (2006.01) C07D 405/12 (2006.01) C07D 451/02 (2006.01)
Patent
CA 2570893
Compounds of formula (I) wherein neither R4 nor R5 is hydrogen; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
L'invention concerne des composés représentés par la formule (I) dans laquelle ni R4 ni R5 ne représente hydrogène, des compositions comprenant lesdits composés, leurs procédés de préparation et leur utilisation en thérapie médicale (par exemple, pour moduler l'activité des récepteurs CCR5 chez un animal à sang chaud).
Faull Alan
Tucker Howard
Astrazeneca Ab
Fetherstonhaugh & Co.
LandOfFree
Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1445805